A lawsuit against pulse oximeter manufacturers and distributors is starting to create change. But experts say the FDA needs ...

Medtronic and Recor Medical, Inc. (and its parent company, Otsuka Medical Devices Co., Ltd.) separately and independently ...

Medtronic plc added a second U.S. FDA pulsed field ablation (PFA) device approval to its scorecard with the agency’s greenlight for its Affera mapping and ablation system with the Sphere-9 catheter.

(Courtesy of Medtronic) At the time, pacemakers were “crude devices,” with wires coming out of the person’s body and “they were susceptible like anything that uses wall power,” said ...

The Centers for Medicare & Medicaid Services granted transitional pass-through (TPT) payment status to Medtronic and Recor Medical for renal denervation devices to treat high blood pressure.

Medtronic announced new long-term data from the SPYRAL HTN-ON MED clinical trial of the company’s Symplicity Spyral renal ...

One of the largest medical-device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves ...

Within 24 hours of the broadcast, a replay and transcript of the prepared remarks will be available by clicking on the Events link at https://investorrelations.medtronic.com. Looking ahead ...

Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced that it will report financial results for its second quarter of fiscal ...

2024 (and announced by FDA on October 17), the company issued an “Urgent Medical Device Correction” letter, advising users to do the following: From January 2023 to September 2024, Medtronic ...

The webcast can be accessed at https://investorrelations.medtronic.com. Within 24 hours of the broadcast, a replay and transcript of the prepared remarks will be available by clicking on the Events ...